Effect of lactobacillus and metronidazole vaginal suppository compared with metronidazole alone on improvement and recurrence of bacterial vaginosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013071914057N1

Enrollment

130

Registered

2014-03-08

Start date

2013-06-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bactrial vaginosis. Bactrial infection, unspecified

Interventions

The group 1 receives oral metronidazole with Lactobacillus vaginal suppositoriesn

Group 2 receives metronidazole and placebo.

Intervention 1: The group 1 receives oral metronidazole with Lactobacillus vaginal suppositoriesn. Intervention 2: Group 2 receives metronidazole and placebo.

Treatment - Drugs

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 15 to 45; married women; no underlying disease Exclusion criteria: Pregnancy; Having other infections; antibiotics in the last 6 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Diagnosis of Bactrial Vaginosis. Timepoint: Before treatment, one month after the treatment. Method of measurement: Based on Amsel criteria , PH Measurement Kit Merck, Germany.	—

Secondary

Measure	Time frame
Measurment of Vaginal discharge. Timepoint: Before treatment, one monthafter the treatment. Method of measurement: Amsel criteria , PH Measurement Kit Merck, Germany.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactkhadijeh Hekmat

School of Nursing and Midwifery, Medical Sciences, Ahvaz,

roozafzay.s@ajums.ac.irsoror.roozafzay@yahoo.com+98 61 1333 2368

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026